Placebo for cemdisiran is 0.9% saline and will be supplied by the sponsor., Pozelimab, Placebo for pozelimab will be provided in an aqueous buffered solution and supplied by the sponsor., Cemdisiran
R3918-AMD-2326
Phase 3 small_molecule active
Quick answer
Placebo for cemdisiran is 0.9% saline and will be supplied by the sponsor., Pozelimab, Placebo for pozelimab will be provided in an aqueous buffered solution and supplied by the sponsor., Cemdisiran for Geographic Atrophy Secondary to Age-Related Macular Degeneration is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active